Molekule Announces Court Ordered Dismissal of Competitor’s Trademark Infringement Complaint with Prejudice
“We are very pleased with the favorable resolution of this matter and along with it the affirmation of the professionalism of our sales and marketing practices.” said Jason DiBona, CEO of Molekule.
- “We are very pleased with the favorable resolution of this matter and along with it the affirmation of the professionalism of our sales and marketing practices.” said Jason DiBona, CEO of Molekule.
- In response, the Company filed counterclaims (“Counterclaims”) contesting the validity of Sterilumen’s trademark rights and seeking money damages for fraudulent registration thereof.
- By its Order dated March 13, 2023 (the “Order”), the Court agreed with Molekule’s position and ruled the Action dismissed with prejudice.
- Molekule subsequently reached a favorable agreement with Sterilumen to forgo pursuing Molekule’s Counterclaims, among other things.